Different Manifestation of Brucellosis in Pregnancy: Case Reports

Abstract

Brucellosis is a zoonotic disease which is endemic in some areas of Iran. The most common symptoms of brucellosis are fever, nightly sweating, chilling, myalgia, fatigue, back pain and arthralgia. Its misdiagnosis can lead to chronic psychological, physical and socioeconomical harms. Mismanagement of infected pregnant women can jeopardize both maternal and fetal safety as well. In this paper we will discuss brucellosis in 5 pregnant women who revealed different manifestations. Surprisingly, none of them had showed fever but it had become apparent after spontaneous abortion. As pregnancy could be accompanied with symptoms like sweating and back pain, the symptoms of brucellosis had been attributed to normal pregnancy and resulted in diagnosis delay. So the unspecific signs and symptoms of involved cases in second or third trimester could not guide the patients or physicians to diagnose brucellosis promptly which resulted in its prolongation, misdiagnosis and mismanagement. J Microbiol Infect Dis 2016;6(2): 80-83   

Keywords

• Brucellosis,fever,pregnant women,misdiagnosis

References

1. 1. Hotez PJ, Savioli L, Fenwick A. Neglected tropical diseases of the Middle East and North Africa: Review of their prevalence, distribution, and opportunities for control. PLoSNegl Trop Dis 2012;6:e1475.
2. 2. Gwida M, Al Dahouk S, Melzer F, et al. Brucellosis – regionally emerging zoonotic disease? Croat Med J 2010; 51:289-295.
3. 3. Kassiri H, Amani H, Lotfi M. Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran. Asian Pac J Trop Biomed 2013;3:589-594.
4. 4. Roushan MR, Mohrez M, SmailnejadGangi SM, et al. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 2004;132:1109–1114.
5. 5. Sofian M, Aghakhani A, Velayati AA, Banifazl M, Eslamifar A, Ramezani A. Risk factors for human brucellosis in Iran: a case—control study. Int J Infect Dis 2008; 12:157-161.
6. 6. Azizi F, Hatami H, Janghorbani M. Epidemiology and control of common diseases in Iran. 4th ed. Tehran: Khosravi Publications; 2010, p.915.
7. 7. Khan YM, Mah MW, Memish ZA. Brucellosis in Pregnant Women. Clin Infect Dis 2001;32:1172-1177.
8. 8. Elshamy M, Ahmed AI. The effects of maternal brucellosis on pregnancy outcome. J Infect Dev Ctries 2008;2:230-234.

9. 9. Sauret JM, Vilissova N. Human Brucellosis. J Am Board Fam Pract 2002; 15:401-406.
10. 10. Mostafavi E, Asmand M. Trend of brucellosis in Iran from 1991 to 2008. Iranian J Epidemiol 2012; 8:94-101.
11. 11. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis 2012; 6:e1929.
12. 12. Solera J. Update on brucellosis: therapeutic challenges. Int J Antimicrob Agents 2010; 36 Suppl 1:S18-20.
13. 13. Al-Tawfiq JA, Memish ZA. Pregnancy Associated Brucellosis. Recent Pat Antiinfect Drug Discov 2013; 8:47-50.
14. 14. Roushan MR, Baiani M, Asnafi N, Saedi F. Outcomes of 19 pregnant women with brucellosis in Babol, northern Iran. Trans R Soc Trop Med Hyg 2011;105:540-542.
15. 15. Aydın B, Beken S, Akansel R, et al. Prematurity due to maternal brucella infection and review of the literature. Turk J Pediatr 2013; 55:433-437.